Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

MedImmune's HPV vaccine enters phase I

Feb. 18, 1997

Peptide Therapeutics/SmithKline Beecham vaccine technology alliance

Feb. 18, 1997

Immunosuppressants discovered by Merck & Co.

Feb. 18, 1997

Positive phase I safety profile for Immunex's new product candidate

Feb. 14, 1997

Melatonin in immunity, aging and cancer

Feb. 12, 1997

U.S. patent issued for meningococcal B vaccine

Feb. 11, 1997

CEAPRO receives patent coverage for potential vaccine adjuvants

Feb. 7, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Clinical trial data reported for meningitis vaccine

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...